The constant temperature equipment manufacturer Lauda has launched the Mobifreeze M 270, the first mobile battery-powered ultra low-temperature chest freezer, according to the company.
Valuable samples or APIs can be safely stored and transported from -86 °C to -50 °C with high temperature resistance – without dry ice. Natural refrigerants are used to provide active temperature control instead.
Safe storage and transport of valuable samples
The actively temperature-controlled, mobile ultra-low-temperature chest freezer with insulation technology has a battery life of four hours and therefore enables the cold chain to be reliably maintained in intralogistics and for interfactory transport in road logistics.
Delicate and temperature-sensitive substances such as gene therapy medicinal products, monoclonal antibodies or vaccines, which require storage under validated conditions, can now be transported under identical conditions.
Cooling is freely adjustable between -86 °C and -50 °C. If the set limits are exceeded, a warning is provided by an acoustic and visual signal.
An integrated data logger stores the temperature and alarm data. In addition to this, a customer-specific monitoring system can be installed. The Good Distribution Practice (GDP) Guidelines for pharmaceu-tical products can therefore be complied with to the full extent.
Furthermore, the Mobifreeze can be used as a hybrid system with flexible switching between battery and mains operation, stationary use for storage, or mobile use for transport. Transfer processes that pose a risk of damage and contamination to the samples are avoided, which means that the overall logistics are more product-friendly.
Safe, comfortable handling, cost savings, and environmentally friendly operation
Battery operation also means that dry ice, which is a hazardous material, and phase-change materials (PCM for short) can be dispensed with during transport. In particular, dispensing with the former eliminates significant health risks for employees. At the same time, expensive exhaust air systems and specific personal protective equipment are no longer required.
The elimination of the PCMs and dry ice as a consumable, represent a significant cost saving. Natural, future-proof refrigerants are used in the refrigera-tion unit of the Mobifreeze. The ultra-low temperature chest freezer therefore eliminates health risks, offers flexibility, and cuts operating costs.
The freezer is operated via a 4.3" touch screen, whose functionality is also not restricted by gloves. Pass-word-protected user management prevents unauthorized access to configuration parameters.
The mobile ultra-low temperature chest freezer is equipped with two rotating heavy-duty casters, which make movement and steering easy in spite of the volume of 270 l.
The ergonomic handles provide a secure grip and the dead man's brake offers extra safety. In addition to this, the bottom panel and wheels are safeguarded by ram and impact protection. The stable design enables it to be loaded with a forklift truck.
This transport innovation for the biopharmaceutical industry is now available.
